WASHINGTON (AP) — Federal regulators have approved an innovative cancer **** from Seattle Genetics Inc. to treat two rare forms of cancer that ****** the lymph nodes.
The Food and **** Administration says it approved Adcetris to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma. Adcetris uses a targeted antibody to deliver the **** directly to cancerous tumor cells, sparing healthy cells.
